In T-ALL, the most frequent driver mutations were located in NOTCH1, and in BCP-ALL, they were in the RAS signaling pathway (NRAS, KRAS, PTPN11, and FDLT3) (75). The gene discussed is KRAS; the disease is acute lymphoblastic leukemia.